Sign in Subscribe
Telecommunications equipment industry

Network Equipment Technologies Wins Contract to Design Nationwide Communications Backbone Network in the UK

Strategic Insights

— 1 min read

Network Equipment Technologies (N.E.T.) has secured a significant contract with Glaxo, the largest pharmaceutical company in the UK, to design and build a new nationwide communications backbone network. This high-capacity network aims to provide Glaxo with greater flexibility and reduced costs in allocating network services. The new network will replace two separate networks and is expected to be fully operational by April 1995. Glaxo selected N.E.T.'s IDNX Communications Resource Managers (CRMs) for their ability to handle high-speed networking links, including E1, E2, and E3 links.

Key Takeaways:

  • N.E.T. has won a contract to design and build a nationwide communications backbone network for Glaxo in the UK.
  • The new network will replace two separate networks and is comprised of 20 IDNX CRMs, including Model 90s and Model 20s.
  • The network will provide Glaxo with greater flexibility and reduced costs in allocating network services, with an expected unit cost reduction of 24 percent and network capacity expansion of 32 percent.
  • The network is expected to be fully operational by April 1995 and will support various high-speed networking links, including E1 (1.54 Mbps), E2 (8.448 Mbps), and E3 (34 Mbps) links.
  • N.E.T. is the only company to provide bandwidth management for E2 services, which cost-effectively supports the bandwidth gap between the more common E1 and E3 standardized interfaces.
  • Glaxo will have a close working relationship with N.E.T. to provide an enhanced fault and alarm monitoring service, with a network operations specialist to be placed at the Glaxo data center.
  • The N.E.T. IDNX family of Communications Resource Managers consists of five sophisticated networking models that combine efficient multiplexing, intelligent call routing, LAN internetworking, frame relay switching, ISDN signaling, and network management.

Statistics:

  • The new N.E.T. network will reduce unit costs by 24 percent for Glaxo.
  • The network will expand network capacity by 32 percent.
  • The network will support 20 IDNX CRMs, including Model 90s and Model 20s.
  • The network will link 15 Glaxo sites in the UK.
  • N.E.T. has a strong presence in the global network market, with networks installed in more than 50 countries.

Sources:

  • BUSINESS WIRE - Jan. 11, 1995
  • Glaxo - Largest pharmaceutical company in the UK
  • N.E.T. Investor Relations - Ann Candelario, (415) 780-5605
  • Network Equipment Technologies, Inc. - Trademarks and registered trademarks of Network Equipment Technologies, Inc.

Read more